Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[¹⁸F]MK-0947 PET Imaging in Parkinson's Disease
NCT07880379Phase 1Recruiting
- Sponsor
- XingImaging
- Start
- Aug 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of [18F]MK-0947 in Parkinson's disease (PD), sponsored by XingImaging. Primary endpoints: Brain uptake of [¹⁸F]MK-0947 at 1 year, Incidence of Adverse Events at 1 year and 1 more. Started Aug 2026; status: recruiting.
02
Drugs
[18F]MK-0947
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT07880379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07880379.